Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PF-06882961
PF-06882961
The NASH curse strikes again. Pfizer dumps early-stage asset for liver condition
Fierce Biotech
Thu, 07/28/22 - 11:08 am
Pfizer
PF-06882961
NASH
Study: Pfizer's Experimental Diabetes Drug Robustly Reduces Weight and Glucose
BioSpace
Tue, 06/16/20 - 07:02 pm
ADA
diabetes
Pfizer
PF-06882961